These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 18362513)

  • 1. Oxygen delivery enhancers: past, present, and future.
    Borrione P; Mastrone A; Salvo RA; Spaccamiglio A; Grasso L; Angeli A
    J Endocrinol Invest; 2008 Feb; 31(2):185-92. PubMed ID: 18362513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemistry, physiology, and complications of blood doping: facts and speculation.
    Lippi G; Franchini M; Salvagno GL; Guidi GC
    Crit Rev Clin Lab Sci; 2006; 43(4):349-91. PubMed ID: 16769597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial oxygen carriers--the new doping threat in endurance sport?
    Schumacher YO; Schmid A; Dinkelmann S; Berg A; Northoff H
    Int J Sports Med; 2001 Nov; 22(8):566-71. PubMed ID: 11719891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoiesis-stimulating agents and other methods to enhance oxygen transport.
    Elliott S
    Br J Pharmacol; 2008 Jun; 154(3):529-41. PubMed ID: 18362898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood boosting today].
    Audran M; Varlet-Marie E
    Bull Acad Natl Med; 2004; 188(6):945-53. PubMed ID: 15651424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood doping and its detection.
    Jelkmann W; Lundby C
    Blood; 2011 Sep; 118(9):2395-404. PubMed ID: 21652677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant erythropoietin and analogues: a challenge for doping control.
    Pascual JA; Belalcazar V; de Bolos C; Gutiérrez R; Llop E; Segura J
    Ther Drug Monit; 2004 Apr; 26(2):175-9. PubMed ID: 15228161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood doping: risks to athletes' health and strategies for detection.
    Oliveira CD; Bairros AV; Yonamine M
    Subst Use Misuse; 2014 Jul; 49(9):1168-81. PubMed ID: 24766400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Oxygen blood transport and doping].
    Audran M; Connes P; Varlet-Marie E
    Bull Acad Natl Med; 2003; 187(9):1669-79; discussion 1680-3. PubMed ID: 15369237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood transfusions in athletes. Old dogmas, new tricks.
    Lippi G; Banfi G
    Clin Chem Lab Med; 2006; 44(12):1395-402. PubMed ID: 17163813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin and erythropoiesis stimulating agents.
    Debeljak N; Sytkowski AJ
    Drug Test Anal; 2012 Nov; 4(11):805-12. PubMed ID: 22508651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs for increasing oxygen and their potential use in doping: a review.
    Gaudard A; Varlet-Marie E; Bressolle F; Audran M
    Sports Med; 2003; 33(3):187-212. PubMed ID: 12656640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood doping: the flip side of transfusion and transfusion alternatives.
    Cacic DL; Hervig T; Seghatchian J
    Transfus Apher Sci; 2013 Aug; 49(1):90-4. PubMed ID: 23791798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of erythropoiesis-stimulating agents in human anti-doping control: past, present and future.
    Leuenberger N; Reichel C; Lasne F
    Bioanalysis; 2012 Jul; 4(13):1565-75. PubMed ID: 22831473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cobalt chloride administration in athletes: a new perspective in blood doping?
    Lippi G; Franchini M; Guidi GC
    Br J Sports Med; 2005 Nov; 39(11):872-3. PubMed ID: 16244201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biochemistry of drugs and doping methods used to enhance aerobic sport performance.
    Cooper CE
    Essays Biochem; 2008; 44():63-83. PubMed ID: 18384283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin and blood doping.
    Robinson N; Giraud S; Saudan C; Baume N; Avois L; Mangin P; Saugy M
    Br J Sports Med; 2006 Jul; 40 Suppl 1(Suppl 1):i30-4. PubMed ID: 16799100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging drugs: mechanism of action, mass spectrometry and doping control analysis.
    Thevis M; Thomas A; Kohler M; Beuck S; Schänzer W
    J Mass Spectrom; 2009 Apr; 44(4):442-60. PubMed ID: 19373874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-inducible factor stabilizers and other small-molecule erythropoiesis-stimulating agents in current and preventive doping analysis.
    Beuck S; Schänzer W; Thevis M
    Drug Test Anal; 2012 Nov; 4(11):830-45. PubMed ID: 22362605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoiesis equivalence, pharmacokinetics and immune response following repeat hematide administration in cynomolgus monkeys.
    Woodburn KW; Schatz PJ; Fong KL; Beaumier P
    Int J Immunopathol Pharmacol; 2010; 23(1):121-9. PubMed ID: 20378000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.